Nature | Medicine 中文 关注 替雷利珠单抗为基础的移植适用新诊断多发性骨髓瘤诱导治疗：一项 2 期临床试验 Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial nature.com
